Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 8/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 11/20 | 0.38 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14043168 | 0.84 | KMT2A (0.46) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL14050875 | 0.83 | GSK3B (0.43) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL12954361 | 0.81 | GSK3B (0.42) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL12953809 | 0.79 | RAB9A (0.43) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL14301781 | 0.79 | RET (0.46) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL14301243 | 0.78 | GSK3B (0.48) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL13305690 | 0.78 | CDK2 (0.53) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL14418832 | 0.77 | KCNK3 (0.41) | GSK3BMEN1KMT2ANPC1RAB9A | |
| SCHEMBL12953974 | 0.76 | SIRT2 (0.40) | GSK3BMEN1KMT2ACDK2CCNE1 | |
| SCHEMBL12954353 | 0.76 | DDR2 (0.47) | MEN1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008130570-A1 | NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORPORATION (US) | 2008-10-30 | — | — | WO | disclosed |